Economic evaluation of Aclasta (TM) (zoledronic acid 5 mg) versus Actonel (TM) (risedronate) in treatment of Paget's disease
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- March 1, 2006
has subject area
- 0903 Biomedical Engineering (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Endocrinology & Metabolism (Science Metrix)
published in
- Osteoporosis International Journal